Evidence map›Paper›PMID 23925559›Full record

ArticleArchives of pharmacal research2021

The effect of levothyroxine replacement therapy on lipid profile and oxidative stress parameters in patients with subclinical hypothyroid.

Serkan Mutlu, Adem Parlak, Umit Aydogan, Aydogan Aydogdu, Bugra Soykut, Cemal Akay, Kenan Saglam, Abdullah Taslipinar

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of pharmacal research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Association between plasma homocysteine status and hypothyroidism: a meta-analysis.International journal of clinical and experimental medicine · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Serkan MutluDepartment of Family Medicine, Gulhane School of Medicine, Ankara, Turkey. serkanmutlu17@yahoo.com.
Adem ParlakDepartment of Family Medicine, Ağrı Military Hospital, Agri, Turkey.
Umit AydoganDepartment of Family Medicine, Gulhane School of Medicine, Ankara, Turkey.
Aydogan AydogduDepartment of Endocrinology and Metabolic Diseases, Gulhane School of Medicine, Ankara, Turkey.
Bugra SoykutDepartment of Pharmaceutical Toxicology, Gulhane School of Medicine, Ankara, Turkey.
Cemal AkayDepartment of Pharmaceutical Toxicology, Gulhane School of Medicine, Ankara, Turkey.
Kenan SaglamDepartment of Internal Medicine, Gulhane School of Medicine, Ankara, Turkey.
Abdullah TaslipinarDepartment of Endocrinology and Metabolic Diseases, Gulhane School of Medicine, Ankara, Turkey.
Gülhane Askerî Tıp Akademisi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this present study is to investigate the levels of oxidative stress parameters in patients with subclinical hypothyroidism (SH) and the effects of levothyroxine (LT4) replacement therapy on these parameters and lipid profile. At the beginning of the study blood samples were collected from the patients in order to analyse oxidative stress parameters, lipid profile and biochemical markers. After replacement therapy with LT4, in the third month, same tests were performed again. At the baseline superoxide dismutase (SOD) levels were found to be higher in SH patients, compared to the euthyroid group. After LT4 therapy, statistically significant decreases in SOD and catalase levels and increase in HDL-C levels were noticed. LT4 treatment was found to have positive effects on oxidative stress indicators and HDL-C levels.

Indexed as

AdultCase-Control StudiesCholesterol, HDLFemaleFollow-Up StudiesHumansHypothyroidismLipidsMaleOxidative StressSuperoxide DismutaseThyroxineCholesterol, HDLLipidsSuperoxide DismutaseThyroxineCATLevothyroxineLipidOxidative stressSODSubclinical hypothyroidism

Identifiers

PMID23925559
OpenAlexW2086188497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.